Varied Views on VUITY
February 6, 2022
What do refractive experts think about the recently approved presbyopia eye drops?
1 min read
False
Advertisement
February 2022
Welcome to first issue of The Ophthalmologist in 2022! Our Upfront section features the latest industry and research, from the discovery of a new class of retinal cell, right to the chronicles of ophthalmology from our consultant historian ophthalmologist, Andrzej Grzybowski. In our opinion column, Graham Barrett explores modest monovision as a strategy for balancing near and far vision. The cover feature opens a new series we are working on with ARVO and features the association’s leadership team, who discuss how ARVO has developed and overcome challenges over recent years, and the role it has played in their careers. In Cornea and OSD, Che J. Connon outlines his plans to grow cornea to meet the impending need for corneal transplant tissue, and in Cataract and Refractive section, nine renowned surgeons share their perspectives on the recently approved drops for presbyopia. In Glaucoma, we ask three specialists to offer their outlooks on how COVID-19 affected glaucoma management in different parts of the world, and in Retina, Jongmin Kim and Dong-Woo Cho explore how retinal tissue goes from bench to bedside using 3D printing and decellularized ECM. Finally, we sit down with Gladys Atto, ophthalmologist at Moroto Regional Referral Hospital, Moroto, Uganda.
The Template for Transplantation
February 5, 2022
The answer to the growing demand for corneal tissue may be to grow more corneal tissue
1 min read
The Retina Blueprint
February 4, 2022
Taking retinal tissue research from the bench to the bedside with decellularized extracellular matrix bioinks and 3D cell printing
1 min read
One in a Million
February 3, 2022
Sitting Down With… Gladys Atto, ophthalmologist at Moroto Regional Referral Hospital, Moroto, Uganda
1 min read
Closing the Distance
February 1, 2022
How does modest monovision work as a strategy for balancing near and far vision?
1 min read
The Laser's Edge
January 26, 2022
Timeline tracking the key developments that culminated in the production of Norlase LION and LEAF technologies
1 min read
Overthrowing L-ORD
January 17, 2022
A hybrid approach to disease modeling identifies both a gene therapy and diabetes drug with the potential to tackle late-onset retinal degeneration
1 min read
Light the Way
January 12, 2022
A guide to providing the right lighting for patients with sight loss
1 min read
Seeing Dementia Burden Clearly
January 10, 2022
How does cataract removal affect the risk of developing dementia?
1 min read
Browse by Subspecialties
False
Advertisement